Abstract
Rationale
Pharmacological intervention for autism spectrum disorder (ASD) is an important addition to treatment, yet currently available agents target co-morbid psychiatric concerns, such as aggression and irritability. Propranolol, a beta-adrenergic antagonist with anxiolytic effects, has been shown to improve verbal fluency and working memory in adults and adolescents with ASD in single-dose challenges.
Objectives
The present pilot study explores the acute effects of propranolol on a measure of conversational reciprocity in this population. We also examined whether autonomic activity and anxiety moderate or mediate response to the drug, given relationships between these variables and ASD, as well as the drug’s effects.
Methods
In a within-subject crossover design, 20 individuals with ASD received a single dose of propranolol or placebo during two sessions in a double-blinded, counterbalanced manner. After drug administration, participants performed a conversational reciprocity task by engaging in a short conversation with the researcher. Measurements of autonomic activity and anxiety were obtained before and after drug administration.
Results
Propranolol significantly improved performance on the conversational reciprocity task total [d = 0.40] and nonverbal communication domain scores when compared to the placebo condition. However, neither autonomic activity nor anxiety was significantly associated with drug response.
Conclusions
Acute propranolol administration improved conversational reciprocity in ASD. Further exploration of these preliminary findings, as well as other potential treatment response predictors, with serial doses is warranted.
Similar content being viewed by others
References
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Press, Washington
Bal E, Harden E, Lamb D, Van Hecke AV, Denver JW, Porges SW (2010) Emotion recognition in children with autism spectrum disorders: relations to eye gaze and autonomic state. J Autism Dev Disord 40:358–370
Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893–897
Bellini S (2004) Social skill deficits and anxiety in high-functioning adolescents with autism spectrum disorders. Focus Autism Other Dev Stud 19:78–86
Berntson GG, Cacioppo JT, Quigley KS (1993) Respiratory sinus arrhythmia: autonomic origins, physiological mechanisms, and psychophysiological implications. Psychophysiology 30:183–196
Beversdorf DQ, Carpenter AL, Miller RF, Cios JS, Hillier A (2008) Effect of propranolol on verbal problem solving in autism spectrum disorder. Neurocase 14:378–383
Beversdorf DQ, Saklayen S, Higgins KF, Bodner KE, Kanne SM, Christ SE (2011) Effect of propranolol on word fluency in autism. Cogn Behav Neurol 24:11–17
Bodner KE, Beversdorf DQ, Saklayen SS, Christ SE (2012) Noradrenergic moderation of working memory impairments in adults with autism spectrum disorder. J Int Neuropsychol Soc 18:556–564
Charney DS, Redmond D (1983) Neurobiological mechanisms in human anxiety evidence supporting central noradrenergic hyperactivity. Neuropharmacology 22:1531–1536
Cook EH, Leventhal BL, Heller W, Metz J, Wainwright M, Freedman DX (1990) Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. J Neuropsychiatry Clin Neurosci 2:268–274
Dadds M, MacDonald E, Cauchi A, Williams K, Levy F, Brennan J (2014) Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial. J Autism Dev Disord 44:521–531
Damasio AR (1996) The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 351:1413–1420
Dawson ME, Schell AM, Filion DL (2007) The electrodermal system. In: Cacioppo JT, Tassinary LG, Berntson GG (eds) The handbook of psychophysiology, 3rd edn. Cambridge University Press, New York, pp 159–181
Erickson C, Posey D, Stigler K, Mullett J, Katschke A, McDougle C (2007) A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl) 191:141–147
Erickson C, Veenstra-Vanderweele J, Melmed R, McCracken J, Ginsberg L, Sikich L et al (2014) STX209 (Arbaclofen) for autism spectrum disorders: an 8-week open-label study. J Autism Dev Disord 44:958–964
Faigel HC (1991) The effect of beta blockade on stress-induced cognitive dysfunction in adolescents. Clin Pediatr 30:441–445
Farmer C, Thurm A, Grant P (2013) Pharmacotherapy for the core symptoms in autistic disorder: current status of the research. Drugs 73:303–314
Gaus V (2011) Adult Asperger syndrome and the utility of cognitive-behavioral therapy. J Contemp Psychother 41:47–56
Geschwind DH (2009) Advances in autism. Annu Rev Med 60:367–380
Gillott A, Furniss F, Walter A (2001) Anxiety in high-functioning children with autism. Autism 5:277–286
Gillott A, Standen PJ (2007) Levels of anxiety and sources of stress in adults with autism. J Intellect Disabil 11:359–370
Guy L, Souders M, Bradstreet L, DeLussey C, Herrington J (2014) Brief report: emotion regulation and respiratory sinus arrhythmia in autism spectrum disorder. J Autism Dev Disord 44:2614–2620
Hasselmo ME, Linster C, Patil M, Ma D, Cekic M (1997) Noradrenergic suppression of synaptic transmission may influence cortical signal-to-noise ratio. J Neurophysiol 77:3326–3339
Hirstein W, Iversen P, Ramachandran VS (2001) Autonomic responses of autistic children to people and objects. Proc R Soc Lond B Biol 268:1883–1888
Heilman KJ, Bal E, Bazhenova OV, Sorokin Y, Perlman SB, Hanley MC et al (2008) Physiological responses to social and physical challenges in children: quantifying mechanisms supporting social engagement and mobilization behaviors. Dev Psychobiol 50:171–182
Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L et al (2007) Oxytocin increases retention of social cognition in autism. Biol Psychiatry 61:498–503
Judd CM, Kenny DA, McClelland GH (2001) Estimating and testing mediation and moderation in within-subjects designs. Psychol Methods 6:115–134
Kerns CM, Maddox BB, Kendall PC, Rump K, Berry L, Schultz RT et al (2015) Brief measures of anxiety in non-treatment-seeking youth with autism spectrum disorder. Autism 19(8):969–979. doi:10.1177/1362361314558465
Lader M (1988) β-adrenoceptor antagonists in neuropsychiatry: an update. J Clin Psychiatry 49:213–223
Lake C, Ziegler MG, Murphy DL (1977) Increased norepinephrine levels and decreased dopamine-β-hydroxylase activity in primary autism. Arch Gen Psychiatry 34:553–556
Launay J, Bursztejn C, Ferrari P, Dreux C, Braconnier A, Zarifian E et al (1987) Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children. J Autism Dev Disord 17:333–347
Lewis GF, Furman SA, McCool MF, Porges SW (2012) Statistical strategies to quantify respiratory sinus arrhythmia: are commonly used metrics equivalent? Biol Psychol 89:349–364
Lord C, Rutter M, Couteur A (1994) Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659–685
Minderaa RB, Anderson GM, Volkmar FR, Akkerhuis GW, Cohen DJ (1994) Noradrenergic and adrenergic functioning in autism. Biol Psychiatry 36:237–241
Ming X, Julu PO, Brimacombe M, Connor S, Daniels ML (2005) Reduced cardiac parasympathetic activity in children with autism. Brain Dev 27:509–516
Montoya AK, Hayes AF (2015) Two condition within-participant statistical mediation analysis: a path-analytic framework., Under review
Myers SM, Johnson CP (2007) Management of children with autism spectrum disorders. Pediatrics 120:1162–1182
Narayanan A, White C, Saklayen S, Scaduto M, Carpenter A, Abduljalil A et al (2010) Effect of propranolol on functional connectivity in autism spectrum disorder: a pilot study. Brain Imaging Behav 4:189–197
Neuhaus E, Bernier R, Beauchaine T (2014) Brief report: social skills, internalizing and externalizing symptoms, and respiratory sinus arrhythmia in autism. J Autism Dev Disord 44:730–737
Patriquin MA, Scarpa A, Friedman BH, Porges SW (2013) Respiratory sinus arrhythmia: a marker for positive social functioning and receptive language skills in children with autism spectrum disorders. Dev Psychobiol 55:101–112
Pitzalis MV, Mastropasqua F, Massari F, Passantino A, Totaro P, Forleo C et al (1998) β-blocker effects on respiratory sinus arrhythmia and baroreflex gain in normal subjects. Chest 114:185–191
Porges SW (1985) Method and apparatus for evaluating rhythmic oscillations in aperiodic physiological response systems. Patent Number: 4,510,944. U.S. Patent Office, Washington
Porges SW (1995) Cardiac vagal tone: a physiological index of stress. Neurosci Biobehav Rev 19:225–233
Porges SW (2005) The vagus: a mediator of behavioral and physiologic features. In: Bauman ML, Kemper TL (eds) The neurobiology of autism, 2nd edn. The Johns Hopkins University Press, Baltimore, pp 65–78
Porges SW (2007) The polyvagal perspective. Biol Psychol 74:116–143
Porges SW, Bohrer RE (1990) Analyses of periodic processes in psychophysiological research. In: Cacioppo JT, Tassinary LG (eds) Principles of psychophysiology: physical, social, and inferential elements. Cambridge University Press, New York, pp 708–753
Ratey JJ, Bemporad J, Sorgi P, Bick P, Polakoff S, O’Driscoll G et al (1987) Brief report: open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults. J Autism Dev Disord 17:439–446
Schaaf RC, Benevides TW, Leiby BE, Sendecki JA (2013) Autonomic dysregulation during sensory stimulation in children with autism spectrum disorder. J Autism Dev Disord 45:461–472
Spence SH (1998) A measure of anxiety symptoms among children. Behav Res Ther 36:545–566
Stichter JP, Herzog MJ, O’Connor KV, Schmidt C (2012) A preliminary examination of a general social outcome measure. Assess Eff Interv 38:40–52
Tordjman S, McBride PA, Hertzig ME, Snow ME, Anderson GM, Hall LM et al (1997) Plasma β-endorphin, adrenocorticotropin hormone, and cortisol in autism. J Child Psychol Psychiatry 38:705–715
Volkmar FR (2001) Pharmacological interventions in autism: theoretical and practical issues. J Clin Child Adolesc 30:80–87
Ward MM, Mefford IN, Parker SD, Chesney MA, Taylor CB, Keegan DL et al (1983) Epinephrine and norepinephrine responses in continuously collected human plasma to a series of stressors. Psychosom Med 45:471–486
Wechsler D (1999) Wechsler abbreviated scale of intelligence. The Psychological Coorporation, San Antonio
Young NJ, Findling RL (2015) An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Curr Opin Psychiatry 28:91–101
Zamzow RM, Christ SE, Saklayen SS, Moffitt AJ, Bodner KE, Higgins KF et al (2014) Effect of propranolol on facial scanning in autism spectrum disorder: a preliminary investigation. J Clin Exp Neuropsychol 36:431–445
Acknowledgments
The study was supported by a grant from the Health Resources and Services Administration (1R40MC19926). We thank our many research assistants for their help with data collection and Nicole Takahashi and Jill Akers at the University of Missouri Thompson Center for Autism and Neurodevelopmental Disorders for their assistance with recruitment. We are grateful to all participants and their families who participated in this study. The experiments presented in this manuscript comply with the current US laws. This study was supported in part by the Center for Cognitive Aging and Memory at the University of Florida, the McKnight Brain Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflict of interest related to the present study.
Rights and permissions
About this article
Cite this article
Zamzow, R.M., Ferguson, B.J., Stichter, J.P. et al. Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study. Psychopharmacology 233, 1171–1178 (2016). https://doi.org/10.1007/s00213-015-4199-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-015-4199-0